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Ultrafast Flow Quantification With Segmented k-Space Magnetic
Resonance Phase Velocity Mapping
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ILaboratory of Biotluid Mechanics and Cardiovascular Imaging, Department of Chemical Engineering, Cleveland Slate University,
Cleveland, OH; 2Scc1ion of Cardiovascular Imaging, Division of Radiology. The Cleveland Clinic Foundation, Cleveland,
OH; and 3Magnclic Resonance Division, Siemens Medical Systems, Chicago, lL

INTRODU CTION

(2)

Magnetic resonance (MR) phase-velocity mapping
(PVM) is a technique that has been widely used clinically to measure blood flow. The technique provides traditional anatomical information using MR imaging and
blood velocity information in any spatial direction using
the phase-velocity encoding technique . This technique is
based on the fact that, by using the proper magnetic-field
gradients, the velocity can be encoded within the phase
of the detected signal. This phase-velocity encoding follows a li near equation:
(I )
where 4> is the phase of the received signal (rad), "y is the
gyromagnetic ratio (HzIT), II is the velocity (assumed
constant) (m/s), and M, is the first moment of the gradient wave ronn (T s2/m) at the echo ti me (TE):

where C(t) is the magnetic-field gradient (TIm). Two
acquisitions are perromled, one in which the velocity is
compensated and one in which the velocity is encoded.
By subtracting the two images pixel by pixel with respect to the phase or the signal, a phasc image can be
constructed which contains velocity inrormation jor each
pixel according to Eq. (I).
Modern PVM was invented in 1982 by Moran. 24
There have been many in vitro and clinical stud ies evaluating the potential and reliability or PVM for now characterization or quantification . In vitro, the accuracy
of PVM was found 10 be consistently high, with errors
of less than 10%.4- 6.8.12.21 In vivo studies showed a
good correlation between PVM and conventional velocimetric
(Doppler
ultrasound)
and
Rowmetric
techniques. 4 • 13•21.22.26.27 The clinical application or r VM
to quantiry or visualize blood Row in the heart, through
heart valves, and in the great vessels has been
extensive.3.1·16- 18.22.26.JO With the development or more
powerrul hardware and software, flow quantification in

TABLE 1. Flow conditions.
Tube No.

Tube ID (cm)

Steady ﬂow rate
(ml/s)

Pulsatile ﬂow volume
(ml/cycle)

1
2
3
4

0.56
1.47
2.02
2.62

1.7, 5, 8.3, 16.7
6.7, 16.7, 66.7, 116.7
10, 25, 33.3, 83.3, 166.7
16.7, 50, 116.7, 200

6
20 and 30
40 and 60
70 and 90

smaller vessels, such as the coronary arteries, has become possible.
Conventional PVM involves a gradient-echo sequence
with bipolar velocity-encoding gradients applied in the
desired direction for velocity measurement. The acquisition can be prospectively or retrospectively referenced to
the ECG signal of the subject in order to acquire a
number of velocity measurements (time phases) throughout the cardiac cycle. Only one line of k-space (frequency domain) is acquired for each phase per heartbeat.
As a result, the acquisition of a single velocity component requires several minutes (typically, 3–5 min, depending on functional and imaging parameters). Considering that blood ﬂow measurement is usually only part of
a complete cardiac MR examination and that new velocimetric diagnostic approaches have started to involve
multislice and multidirectional velocity acquisitions,8,31,32
this single k-space line (nonsegmented) acquisition technique becomes less practical clinically.
With the development of rapid imaging sequences, it
has become possible to implement PVM much faster.
The two most prominent sequences for ultrafast PVM are
multishot echo-planar imaging (EPI) and turbo gradient
echo (TGE). Instead of acquiring a single k-space line
during each time phase per cardiac cycle, multiple lines
or segments of k-space lines are acquired during each
time phase. Consequently, the acquisition can be performed in seconds, instead of minutes.
The similarity between segmented k-space TGE and
multishot EPI is that both acquire multiple lines or segments of k-space per phase, in contrast to the conventional, nonseqmented, gradient-echo sequence that acquires only a single line. The difference is that in TGE
acquisition of each line of the segment requires a separate excitation, whereas in EPI all lines of the segment
are acquired after a single excitation. Because of the
absence of multiple excitation pulses, EPI is generally
faster. However, the longer effective echo time of EPI
combined with the speciﬁc gradient function of EPI
cause ﬂow-related signal voids, especially in relatively
disturbed ﬂow ﬁelds, and other image artifacts. TGE has
shown better ﬂow behavior and is, therefore, more promising for reliable ultrafast ﬂow quantiﬁcation with relatively disturbed ﬂow and signiﬁcant vessel motion (e.g.,
coronary arteries).9,10,14,20,25 In addition, previous in vitro
and clinical studies2,10,11,14,19,20,23,25,28,29 evaluating both

EPI and TGE techniques for PVM have indicated that
TGE is generally superior in terms of temporal and
(sub-millimeter28) in-plane spatial resolution.
The aim of this study was to evaluate the segmented
k-space TGE sequence in quantifying ﬂow from throughplane velocity measurements. An in vitro study was performed under a variety of ﬂow conditions and imaging
parameters, followed by preliminary clinical measurements.
METHODS
In vitro and in vivo studies were performed in a 1.5 T
Siemens Sonata whole-body MRI scanner (Siemens
Medical Systems, Erlangen, Germany) with a maximum
gradient strength of 40 mT/m. First, in vitro PVM measurements were performed with steady and pulsatile water ﬂow through four straight PVC tubes with inside
diameters of 5.6 mm (tube No. 1), 14.7 mm (tube No. 2),
20.2 mm (tube No. 3), and 26.2 mm (tube No. 4). The
tubes were placed in a water container to insure detection of adequate MR signal. Then, in vivo PVM measurements were performed in the ascending aorta of two
human subjects, one with an ascending aortic aneurysm,
and one with ischemic heart disease.
Experimental Conditions
Steady ﬂow studies were ﬁrst performed using a range
of ﬂow rates (1.7–200 ml/s, Table 1). The Reynolds
number (Re) range studied was 400–10,500. The true
ﬂow rate was known via precalibrated rotameters. Then,
pulsatile ﬂow studies (see the ﬂow loop in Fig. 1) were

FIGURE 1. Pulsatile ﬂow loop.

FIGURE 2. True ﬂow wave form generated by the piston
pump as measured by the MR-compatible ultrasonic ﬂow
probe.

conducted using a computer-controlled piston pump (SuperPump, SPS 3891, Vivitro Systems Inc., Victoria, British Columbia, Canada) to provide ﬂow pulsatility. A
hardware/software system (Vivigen Waveform Generator
VG8991, Vivitro Systems Inc.) was used to program and
download a sinusoidal ﬂow wave form from a PC to the
piston pump. The piston stroke volumes studied were
6 –90 ml/cycle (Table 1) under a rate of 60 cycles/min.
The true ﬂow wave form (Fig. 2) was measured with a
precalibrated, MR-compatible (brass), transit-time ultrasonic ﬂow probe (20N in-line, Transonic Systems, Inc.,
Ithaca, NY). The ﬂow data from the probe was acquired
by a single channel ﬂow meter (T-106, Transonic Systems, Inc.). The ﬂow wave form was recorded on a PC
by digitizing the analog signal from the ﬂow meter with
an analog-to-digital board (PCI-MIO-16E-4, National Instruments Inc., Austin, TX), using the LabVIEW software (Version 5.0, National Instruments, Inc.). Integration of the ﬂow curve during the cycle provided the true
ﬂow volume.
In Vitro Imaging Procedure
The test section (water-ﬁlled container with submerged straight tubes) was connected to the ﬂow loop,
and the entire system was inserted into the bore of the
scanner with the test section placed at the isocenter.
Initial true fast imaging with steady-state precession
(FISP) scout images in all three spatial orientations
(axial, coronal, and sagittal) showed the location of the
tubes. An imaging slice was then placed axially, perpendicular to the long axis of the tube under study. Three
PVM acquisitions of the through-plane velocity were
performed for each ﬂow condition, using the following
three sequences: (a) conventional nonsegmented gradient
echo with one k-space line per time phase and cycle; (b)
segmented TGE with ﬁve k-space lines per time phase
and cycle; and (c) segmented TGE with nine lines per

time phase and cycle. In all sequences, the ﬂow-sensitive
and the ﬂow-compensated data (which were subtracted to
provide the phase data) were acquired in an interleaved
manner in the same cycle. The ﬂip angle was 30°. The
slice thickness (ST) was 5 or 3 mm. The ﬁeld of view
(FOV) was 160X160 mm2 (for tube No. 1), 200X200
mm2 (for tube Nos. 1, 2, and 3), and 300X300 mm2 (for
tube Nos. 2, 3, and 4). The acquisition matrix size was
192X256 for sequence (a), 140X256 for sequence (b),
and 144X256 for sequence (c). The nominal voxel size
varied between 0.6X0.8X3 and 0.6X1.6X5 mm3 for
sequence (a), between 0.6X1.1X3 and 0.6X2.1X5 mm3
for sequence (b), and between 0.6X1.1X3 and 0.6
X2.1X5 mm3 for sequence (c). Therefore, for a reconstructed matrix of 256X256, the voxel size (after interpolation) varied from 0.6X0.6X3 to 1.2X1.2X5 mm3
in all sequences. The shortest possible TE (2.3–3.5 ms)
was used. In sequence (a), the repetition time (TR) was
30 ms. In sequences (b) and (c), the time to acquire data
for any one k y line (actual TR) varied between 5.2 and
5.6 ms, depending on the imaging parameters, such as
ST and FOV. The echo was acquired asymmetrically
within the data acquisition period. The peak of the echo
occurred at data-point 82 of 256 and the missing data
points were zero ﬁlled. The velocity encoding value
(above which aliasing would take place) was 20–150
cm/s, depending on the magnitude of the ﬂow.
In the case of pulsatile ﬂow, a transistor–transistor
logic (TTL) signal synchronized with the piston pump
ﬂow wave form triggered the scanner to acquire multiple
time phases throughout the cycle. The procedure was
similar to the standard clinical situation in which the
ECG signal from the subject is used to trigger the scanner for data acqusition. Using echo view sharing (adjacent time phases shared some of the acquired k-space
lines), the temporal resolution was further improved in
the segmented sequences [30 ms for sequence (a), 30– 45
ms for sequence (b), and 50– 65 ms for sequence (c)].
The time corresponding to each phase was the time of
acquisition of the central line of the segment, since that
line contained the most useful velocity information of the
segment. The number of time phases during the 1 s cycle
was 31 for sequence (a), 22–31 for sequence (b), and
15–20 for sequence (c). The scanning duration was 3.2
min for sequence (a), 28 s for sequence (b), and 16 s for
sequence (c).
Clinical Measurements
To evaluate the clinical potential of segmented
k-space PVM in quantifying blood ﬂow, preliminary
measurements were performed in two human subjects
(subject No. 1: male, 70 years old, ascending aortic aneurysm; subject No. 2: male, 60 years old, ischemic heart
disease). Velocity data were acquired with a slice positioned in the ascending aorta of each subject, at the level

of the pulmonary artery bifurcation. Two sequences were
used: (i) the conventional nonsegmented gradient echo;
and (ii) the segmented TGE with nine lines per segment.
ECG gating was used to acquire multiple time phases
throughout the cardiac cycle. The sequence with ﬁve
lines per segment used in the in vitro measurements was
not tested in the in vivo part, because of its long duration
(�25 s; more difﬁcult to be performed within a breath
hold). The ST was 5 mm for both subjects. The scan
percentages were 75% and 56% for sequences (i) and
(ii), respectively. The FOV was 263X350 mm2 for subject No. 1 (rectangular FOV factor of 75%), and 225
X300 mm2 for subject No. 2 (rectangular FOV factor of
75%). Combination of the scan percentage with the rectangular FOV factor resulted in acquired numbers of 144
and 108 k y lines for sequence (i) and (ii), respectively.
The velocity encoding value was 250 cm/s, and the rest
of the imaging parameters were as in the in vitro part.
The scan durations for the ﬁrst sequence were 2.4 and
2.1 min for subject Nos. 1 and 2, respectively. The second sequence was performed within a breath hold (12
and 11 s for subject Nos. 1 and 2, respectively). For
subject No. 1, the numbers of time phases acquired were
31 for the nonsegmented sequence and 19 for the nineline segmented sequence. For subject No. 2, these numbers were 25 and 15, respectively.

Data Analysis
Each PVM acquisition produced a magnitude and a
phase image (or a series of magnitude and phase images
during the cycle under pulsatile ﬂow and in the clinical
cases). All images were transferred to a work station
(Ultra-10, SUN Microsystems, Inc., Palo Alto, CA). A
computer program was used to convert the phase values
of the phase images to velocity values (cm/s), based on
Eq. (1). Then, the images were visualized using TRANSFORM (Version 3.4, Research Systems, Inc., Boulder,
CO). The tube (in vitro) or the aortic (in vivo) cross
section was clearly visualized and selected, and the ﬂuid
velocity was integrated over the tube/aortic crosssectional area to ﬁnd the ﬂow rate (ml/s). For the pulsatile ﬂow in vitro data and for the clinical ﬂow data,
integration of the ﬂow curve over the cycle provided the
ﬂow volume (ml/cycle).
Regression analysis, nonparametric statistical tests
(sign test),15 and Bland–Altman analysis1 were performed to compare the PVM-measured ﬂow values with
the true ﬂow values (in vitro) and the ﬂow data from the
segmented techniques with the ﬂow data from the nonsegmented technique (in vitro and in vivo). The MINITAB
software (Version 13, Minitab, Inc., State College, PA)
was used for the statistical analysis. A p value<0.05
demonstrated a signiﬁcant difference.

FIGURE 3. Magnitude „a… and phase „b… images acquired
using the nonsegmented PVM sequence. Magnitude „c… and
phase „d… images using the segmented phase velocity mapping „PVM… sequence with nine lines per segment. The
phase images contain †encoded according to Eq. „1…‡ the
velocity information.

RESULTS
Figure 3 shows the magnitude and phase images from
nonsegmented and nine-line segmented PVM acquisitions in the in vitro case. Both images from the nonsegmented [Figs. 3(a) and 3(b)] and the segmented [Figs.
3(c) and 3(d)] sequences were of sufﬁcient quality for
analysis and ﬂow quantiﬁcation.
Figure 4 shows the measured velocity proﬁles in the
case of laminar (Re=580), and non-laminar (Re=5250)
steady ﬂow for the nonsegmented acquisition and the
segmented with nine lines of k-space per segment. The
velocity was normalized with respect to the crosssectional average velocity. The velocity proﬁles are very
similar in the nonsegmented and the segmented cases for

FIGURE 4. Normalized velocity proﬁles as measured using
the nonsegmented „slow… sequence and the segmented „ultrafast… sequence with nine k-space lines per segment. Normalization was performed by dividing the local velocity values with the average cross-sectional velocity. „a… Laminar
ﬂow; „b… nonlaminar ﬂow.

TABLE 2. Regression analysis and sign test results for the steady ﬂow data.
Y (ml/s)

X (ml/s)

Segb-5
Seg-9
Seg-5
Seg-9

True
True
Non-Segc
Non-Seg

Regression equation

Y =1.04
Y =1.05
Y =1.01
Y =1.02

X – 0.61
X – 0.77
X – 0.44
X – 0.63

R2

SEa (ml/s)

Sign test p value

0.990
0.989
0.998
0.998

6.2
6.5
3.1
3.0

0.33
0.89
0.33
0.49

a

SE: standard error.
Seg: segmented k-space sequence.
c
Non-Seg: Nonsegmented k-space sequence.
b

both ﬂow regimes. In laminar ﬂow, the proﬁle is parabolic, whereas in nonlaminar ﬂow, the proﬁle is ﬂatter.
The ratio of the cross-sectional average velocity to the
maximum measured velocity was found to be approximately 0.55 for Re=580 and 0.80 for Re=5250. The
velocity gradient approaching the wall is greater in nonlaminar ﬂow than in laminar ﬂow.
The known accuracy of the nonsegmented
sequence4 – 6,8,12,21 was conﬁrmed in this study (Y =1.03
X – 0.04, R 2 =0.988, standard error=6.7 ml/s; Y: measured ﬂow rate, X: true ﬂow rate). Close agreement between the measured ﬂow rate from the two segmented
sequences and the true ﬂow (from the rotameters), as
well as between the ﬂow rate from the two segmented
(ultrafast) sequences and the ﬂow rate from the nonsegmented (slow) sequence was found with regression
analysis (Table 2). The agreement was also conﬁrmed by
sign tests which produced p values much greater than
0.05 in all cases.
The accuracy of the ﬂow rate measurements under
nonlaminar ﬂow conditions was found to be comparable
to that of the laminar ﬂow. The mean errors [(measuredtrue)/true] for laminar ﬂow were 1.6%, 1.6%, and 0.1%
for the nonsegmented, ﬁve-line segmented, and nine-line
segmented sequences, respectively; for the nonlaminar
case, the errors were 5.1%, 3.6%, and 4.5%, respectively.
Sign tests conﬁrmed the high accuracy of the measured

FIGURE 5. Measured ﬂow wave forms under pulsatile ﬂow
conditions. „a… True ﬂow volumeÄ20 mlÕcycle; measured
ﬂow volumeÄ17.9, 20.8, and 20.2 mlÕcycle for the nonsegmented, the ﬁve-line segmented and the nine-line segmented
sequences, respectively. „b… True ﬂow volume Ä 70 mlÕcycle;
measured ﬂow volumeÄ71.7, 76.0, and 75.0 mlÕcycle for the
nonsegmented, the ﬁve-line segmented and the nine-line
segmented sequences, respectively.

ﬂow rates showing comparable p values (�0.05) for both
the laminar and nonlaminar ﬂow cases.
Figure 5 shows the measured ﬂow wave forms for
true ﬂow volumes of 20 and 70 ml/cycle in the pulsatile
ﬂow studies. The measured ﬂow curves for the different
sequences are very similar both qualitatively and quantitatively. Figure 6 shows the comparison between the
PVM-measured ﬂow volumes with all three sequences
(the nonsegmented and the two segmented) and the true
ﬂow volume known via the ﬂow probe. The mean errors
were 3.3%, 0.1%, and 0.5% for the nonsegmented, ﬁveline segmented, and nine-line segmented sequences, respectively. Table 3 shows the regression analysis results
between the three sequences and the ﬂow probe (true)
values as well as between the two segmented (fast) sequences and the nonsegmented (slow) one. As in the
steady ﬂow case, the results show a very good agreement
between the measured and the true ﬂow rate values for
all sequences, and a very good agreement between the
segmented and the nonsegmented sequences. These ﬁnd-

FIGURE 6. Comparison between the PVM-measured and the
true ﬂow volumes under pulsatile ﬂow conditions for all sequences used „Non-Seg: nonsegmented acquisition; Seg-5:
segmented acquisition with ﬁve k-space lines per segment;
and Seg-9: segmented acquisition with nine k-space lines
per segment….

TABLE 3. Regression analysis and sign test results for the pulsatile ﬂow data.
Y
(ml/cycle)
b

Seg -5
Seg-9
Seg-5
Seg-9

X
(ml/cycle)

Regression equation

R

True
True
Non-Segc
Non-Seg

Y =1.08 X – 1.65
Y =1.12 X – 2.52
Y =1.02 X +1.21
Y =1.07 X +0.10

0.983
0.971
0.954
0.958

2

SEa
(ml/cycle)

Sign test p value

3.7
5.1
6.1
6.1

0.84
0.84
0.13
0.17

a

SE: standard error.
Seg: Segmetned k-space sequence.
c
Non-Seg: Nonsegmetned k-space sequence.
b

ings were conﬁrmed by sign tests (Table 3), in which all
p values are greater than 0.05. In addition, Fig. 7 shows
the Bland–Altman analysis plot for the comparison between the measured ﬂow volumes with the nine-line segmented sequence and the true ﬂow volumes. The mean
and the standard deviation are low (approximately 0.3
and 2.9 ml/cycle, respectively), and the data points are
within the ‘‘:2 standard deviations’’ lines. Similar analysis was performed to compare the ﬂow volumes from the
other sequences with the true ﬂow volumes, and the
results were identical to the ones presented for the nineline segmented sequence.
Under both steady and pulsatile ﬂow conditions, slice
thickness and ﬁeld of view did not seem to affect the
accuracy of the results. Sign tests showed no signiﬁcant
differences (p�0.05) between the two STs (3 vs 5 mm)
and the different FOVs.
The aortic ﬂow measurements in the two human subjects showed a close agreement between the nonsegmented and the nine-line segmented sequences. The ﬂow
wave forms were almost identical (Fig. 8). Integration of
the ﬂow curves over the entire cardiac cycle showed
agreement (difference =3%) in the calculated ﬂow volumes between the nonsegmented sequence and the nine-

FIGURE 7. Bland–Altman analysis plot comparing the measured and true ﬂow volumes for the nine-line segmented
sequence.

line segmented sequence (subject No. 1, nonsegmented:
88.1 ml/beat, segmented: 86.1 ml/beat; subject No. 2,
nonsegmented: 54.6 ml/beat, segmented: 56.4 ml/beat).

DISCUSSION
Magnetic resonance phase velocity mapping is a reliable velocimetric and ﬂow quantiﬁcation technique. It
has been clinically used to measure the ﬂow rate and
analyze the ﬂow patterns in the heart and vessels such as
the entire aorta, the carotid arteries, the renal arteries,
cerebral and peripheral vessels, and small vessels such as
the coronary arteries. The accuracy and reliability of
PVM has been shown through a number of in vitro and
in vivo studies in the past. Nevertheless, conventional
nonsegmented PVM is relatively slow. It takes 3–5 min
for a single measurement. Fast techniques are necessary
to make PVM more practical clinically. This study attempted to evaluate two segmented PVM acquisition
schemes, one with ﬁve k-space lines per segment and
one with nine lines per segment, and compare the ﬂow

FIGURE 8. Measured ﬂow wave forms in the ascending aorta
„level of pulmonary artery bifurcation… of a patient with an
ascending aortic aneurysm using the nonsegmented sequence and the nine-line segmented sequence „Non-Seg:
nonsegmented acquisition; Seg-9: segmented acquisition
with nine k-space lines per segment….

results to those acquired with the nonsegmented sequence as well as with true ﬂow values. PVM measurements under steady and pulsatile ﬂow conditions showed
that both segmented sequences provided equally accurate
and reliable results. Increasing the number of k-space
lines to nine did not show any negative effect on the
measured ﬂow.
Image quality was very good for all sequences used
(Fig. 3) and for all ﬂow conditions facilitating image
analysis and processing. Under laminar ﬂow conditions,
the ﬂow proﬁles were parabolic and smooth [Fig. 4(a)].
The centerline velocity was almost twice as large as the
average cross-sectional velocity. Under nonlaminar ﬂow
conditions, the proﬁles were ﬂatter and the maximum
velocity was much less than twice the cross-sectional
average velocity [Fig. 4(b)]. The velocity gradient towards the wall was greater in nonlaminar ﬂow than in
laminar ﬂow. This agreement of the measured velocity
proﬁles with what is theoretically and empirically expected (parabolic proﬁles for laminar ﬂow, ﬂat-like proﬁles for nonlaminar ﬂow) reﬂects the velocimetric reliability of the MR PVM technique. Although the in-plane
spatial resolution was adequate to obtain the details of
the velocity proﬁle, an even higher resolution would better resolve the velocity gradient immediately adjacent to
the tube wall. This would be important to calculate wall
shear stress. It should be noted that, technically, it was
possible to increase spatial resolution by further decreasing the voxel size. However, the effects of reducing
voxel size on the signal-to-noise ratio and thus image
quality need to be thoroughly investigated by taking into
account that there is always a distance between optimal
in vitro resolution and optimal in vivo resolution. In
addition, improving the resolution means lengthening the
acquisition, which is undesired clinically. This limitation
at the wall did not affect the quantiﬁcation of ﬂow rate,
because of the lower velocity magnitudes near the wall
and the small contribution of those pixels to the overall
ﬂow rate.
Of interest is the high accuracy (errors�5%) of the
ﬂow rate results under nonlaminar ﬂow conditions. Traditionally, MR imaging has shown limitations in measuring the velocity in regions with turbulence, because of
voxel signal loss due to velocity ﬂuctuations. Signal loss
automatically means loss of the phase (velocity) information. The technological advancement in MR hardware
has led to improved magnetic-ﬁeld gradient performance,
which in combination with decreased echo times (the
time between tissue excitation and signal readout) can
reduce the effects of turbulence on the voxel signal quality, thus allowing velocity measurements under disturbed
ﬂow conditions. This study used very small TEs (as low
as 2.3 ms), because of the ability to operate the very
strong magnetic-ﬁeld gradients very fast. As a result,
PVM acquisition provided clear images in which the

signal was not reduced. This led to accurate velocity
information, which, in turn, resulted in accurate ﬂow rate
quantiﬁcation.
It should be emphasized, however, that the results of
this study do not show that turbulent ﬂow is universally
quantiﬁable by PVM. There are many ﬂuid mechanics
and technical factors involved that need investigation to
draw safe conclusions on this matter. This study merely
showed that under the studied range of Re (400–10,500),
ﬂow can be measured very accurately by ultrafast PVM
sequences. Further investigations are necessary, under
larger Re to show the relationship between decreasing
TE and the ability to measure turbulent ﬂow with PVM.
The pulsatile ﬂow results (ﬂow volumes) showed
similar levels of accuracy (errors<5%) as the steady
ﬂow results. The measured ﬂow curves were very similar
in all PVM sequences used (Fig. 5). A similar agreement
was observed in the two in vivo cases examined. It
should be noted that, in segmented PVM with n lines per
segment (in which n is an odd number), the most useful
information is contained in the central line, (n+1)/2, of
the segment, because this is the closest line of the segment to the center of k-space. Therefore, the time corresponding to any phase acquired during the cycle was
adjusted to be the time of acquisition of the central
k-space line of the segment. Without such an adjustment,
a temporal shift of the ﬂow curves would take place, as
previously observed.28 This shift would increase with the
number of lines per segment. Combination of this temporal adjustment with retrospective ECG gating is necessary clinically to avoid loss of information in the very
beginning and the very end of the cycle.
The close agreement of the calculated ﬂow rates and
ﬂow volumes with the true ﬂow values, as well as the
agreement of the velocity proﬁles, ﬂow rates, ﬂow volumes, and ﬂow wave forms between the sequences, suggest that accurate ﬂow quantiﬁcation is possible using
ultrafast segmented PVM. The high in vitro accuracy of
the faster nine-line sequence, in combination with its
good temporal resolution (� 10 phases per cycle) and
shorter duration (<20 s) compared to the ﬁve-line sequence, makes it preferable, considering the difﬁculty
some patients have with longer breath holds. This is
further supported by the preliminary clinical agreement
found between the nonsegmented and the nine-line segmented ﬂow results in the two subjects examined in this
study. A larger clinical study will provide more information about the clinical feasibility, advantages, and problems of segmented PVM techniques.
The in vitro part of this study evaluated two segmented PVM sequences using straight rigid tubes under
a variety of ﬂow conditions and imaging parameters.
Flow conditions (range, pulsatility) and tube size partially simulated what is observed clinically, but no other
physiologic factors, such as wall compliance, wall mo-

tion, presence of stenosis, tube curvature, branching, etc.,
were studied. The aim of this study was to focus on the
sequences and evaluate them under relatively simple
ﬂow environments without involving other factors which
would complicate the situation. Nevertheless, further
evaluation of these sequences under more physiological
environments and conditions, and using all three spatial
velocity components, is necessary in order to further
increase their reliability and broaden their clinical applicability.
Increasing the number of k-space lines per segment
above nine will certainly shorten the acquisition even
more, but at the expense of temporal resolution. Therefore, the number of lines should be increased only after
assuring acquisition of an adequate number of phases per
cycle in order to prevent loss of valuable information,
particularly at peak systole. In addition, it is recommended that, before clinically implementing a sequence,
data from in vitro or in vivo evaluation studies be available to assure reliability.
CONCLUSIONS
Steady and pulsatile ﬂow experiments in straight rigid
tubes showed that k-space segmented PVM provides accurate, ultrafast velocity measurements and ﬂow quantiﬁcation. The technique quantiﬁed laminar and nonlaminar ﬂow up to a Reynolds number of 10,500 with
reliability. Increasing the number of k-space lines per
segment to nine did not show any negative effects on the
ability of PVM to measure ﬂow with high accuracy.
Preliminary clinical ﬁndings agreed with the experimental ﬁndings. As interest in obtaining detailed quantitative
information about blood ﬂow noninvasively is continuously increasing, fast protocols are in demand. Ultra-fast
segmented k-space MR phase velocity mapping shows
promise to clinically satisfy this need.
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NOMENCLATURE
MR
PVM
EPI
TGE
TE
TR
ST
FOV
VENC

magnetic resonance
phase velocity mapping
echo planar imaging
turbo gradient echo
echo time
repetition time
slice thickness
ﬁeld of view
velocity encoding limit value

Re
SE
FISP
TTL

Reynolds number
standard error
fast imaging with steady-state precession
transistor–transistor logic
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P. Hekali, and C.-G. Standertskjöld-Nordenstam. Multiphase
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